Rheumatology

Niccolo Machiavelli and Winston Churchill have both been credited with the advice: “Never waste the opportunity offered by a good crisis.” It would be…

Dr Proft opened the symposium with the case of a 33-year-old female patient referred via the online self-referral tool ‘Bechterew Check’…

This Janssen-sponsored live symposium “Advancing the Treatment of PsA: Focus on the IL-23 Pathway,” took place virtually at the European League Against…

Prof Schett opened the session by explaining the overall theme and objectives of the symposium. Charles Darwin famously visited the Galápagos islands…

Psoriatic arthritis (PsA) is a chronic, heterogeneous, immune-mediated arthritis characterised by joint inflammation and diverse clinical manifestations…

Clinical Prof Daniel Wallace   |  Rheumatologist, Cedars-Sinai Medical Center and Ronald Reagan UCLA Medical Center, Los Angeles,  California, USA…

Spondyloarthritis (SpA) is a chronic systemic rheumatic disease, the hallmark manifestation of which is inflammatory back pain, and may also involve…

Methotrexate (MTX) is the most commonly used medication to treat RA. MTX pneumonitis (MTX-pneu) is a rare disease entity reported in MTX users.

Rheumatoid arthritis (RA) is associated with changes in skeletal health, including increased risk of fracture.

The purpose of this review is to provide a clinically focussed description of the relevant aetiopathogenesis, clinical expression of disease, approach to the assessment and treatment of Systemic Sclerosis, and highlight the recent advances and future challenges associated with this complex disease.

To correlate audiometry with atherosclerosis. Presbycusis is associated  with age and atherosclerosis; a strong correlation might present opportunities to…

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease which predominantly involves the axial skeleton and sacroiliac joints.

In March 2020, the COVID-19 pandemic arrived in Cyprus. Suddenly, our lives and our way of life has been affected in an unprecedented way…

Currently, rheumatologists cannot reliably predict the progression of early undifferentiated arthritis to early RA…

Chronic inflammatory diseases (CID) encompass a wide range of pathologies affecting different organs or bodily functions…

Dr Queiro-Silva opened the session by proposing a definition of the moderate-severity PsA patient: patients associated with a limited number of affected…

Systemic sclerosis (SSc) is a multi-system connective tissue disease characterised by excessive fibrosis, microvasculopathy, and autoimmunity…

The use of ultrasonography has been increasing across many specialties, including rheumatology…

Polymyalgia rheumatica (PMR) and seronegative elderly-onset rheumatoid arthritis (SEORA) are two of the most frequent inflammatory rheumatologic diseases in elderly patients.

Anti-TNF biologics have revolutionised treatment of RA. More recently, the emergence of high-quality biosimilars has provided a cost-effective means of…

Although gender is defined by psychological and social differences between men and women, and sex is defined by biological parameters based on genetics…

Since the 1990s, outcomes for patients with RA have steadily improved over time, with the treatment target for patients evolving from symptomatic relief…

The aim of this symposium was to familiarise participants with the IL-23 pathway and the rationale for targeting this pathway in PsA…

The field of immunometabolism is a rapidly expanding area of research that centres around understanding the interrelationship between immunological and…

Osteoporosis is a systemic skeletal disease characterised by microarchitectural deterioration and high fragility of bone tissue, resulting in low bone…

Although aPL are reported in 1–5% of the general population,2 only a minority of these individuals will develop the clinical manifestations of APS. The incidence of APS…

Psoriatic arthritis (PsA) belongs to the group of diseases known as spondyloarthritis (SpA). The impact of PsA is not limited to just skin and joints…

Adalimumab is a recombinant fully human monoclonal antibody (IgG1 type) targeting soluble and transmembrane TNF. AbbVie’s bio-originator adalimumab…

Apremilast (APR) is a small molecule phosphodiesterase-4 inhibitor that is used in the treatment of psoriasis (PsO) and psoriatic arthritis (PsA)…

Fibromyalgia is a common chronic pain disorder characterised by a robust clinical phenotype with principal features that include widespread pain and…

Osteoarthritis (OA) is the most prevalent form of arthritis worldwide and affects the whole joint. Changes in cartilage integrity, subchondral bone, and…

The most common autoimmune diseases that affect the joints are osteoarthritis (OA) and rheumatoid arthritis (RA). The pathogeneses of both OA and RA are…

Switching patients from a reference to a biosimilar product has become a primary topic of interest, with different approaches being undertaken by the…

This article presents a case of infection after ACL reconstruction and discusses risk factors, treatment choice, antibiotic treatment length, and functional outcomes, proposing a guide for the treatment.

The aim of this review is to illustrate the role of NAD+-related enzymes in the pathogenesis of RA and highlight the potential therapeutic role of NAD+ in RA.

With an increasing number of biosimilars receiving regulatory approval, the treatment landscape for rheumatic diseases is evolving. Healthcare…

Biological disease-modifying antirheumatic drugs have defined a new era in rheumatoid arthritis (RA) management but share the limitation of antagonising…

Biosimilars are more affordable versions of previously approved biopharmaceuticals that are designed to reduce healthcare expenditure and increase…

Primary Sjögren’s syndrome (pSS) is a relatively common disease and one of the most common rheumatic diseases

Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a breakdown in immune tolerance

Autoimmune responses need to be identified and managed promptly to avoid deleterious consequences. Autoimmune diseases, such as rheumatoid arthritis (RA)…

This review analyses the factors responsible for higher ischaemic and haemorrhagic stroke risk in the systemic lupus erythematosus population

Objectives: To examine the combined effectiveness of a care pathway for patients with suspected inflammatory back pain (IBP) in conjunction with an…

Prof Taylor opened the meeting and briefly highlighted the epidemiology of pregnancy in women with chronic rheumatic diseases. Dr Moltó presented the…

Rheumatoid arthritis (RA) is a chronic, disabling, inflammatory, autoimmune disease that affects approximatively 0.4–1.0% of the population. Immune…

Osteoarthritis (OA) is the most common global chronic joint disease. A study into the impact of Osteoarthritis and its impact on ageing

The objective of the symposium was to explain the mechanism behind IL-6 dysfunction in RA pathophysiology, review novel RA therapies…

Prof McGonagle introduced the symposium and briefly described the aims of the meeting.

This commentary reflects our personal approach to the treatment of idiopathic inflammatory myopathies (IIM), also commonly referred to as myositis.

Ankylosing spondylitis is a chronic autoimmune inflammatory condition belonging to the spondyloarthropathy category of rheumatic diseases…

Prof Fernando Perez-Ruiz opened the symposium, which focussed on the current unmet need in controlling gout and associated comorbidities with current…

To mark this year’s World Osteoporosis Day (WOD) on the 20th October 2017, the European Medical Journal spoke to the International Osteoporosis…

Spasmodic dysphonia (SD): what about it? That is the million-dollar question.

The licensing of biosimilars heralds the start of a new era for physicians treating immune and inflammatory diseases.

Biosimilars have been available in Europe since 2006, and biosimilars of monoclonal antibodies since 2013, and are now a widespread clinical reality.

The symposium at the EULAR 2017 congress aimed to provide insights into the burden of psoriatic arthritis on patients’ daily lives, including the…